Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2. The new ...

Xia Baolong is a prominent Chinese politician with extensive experience in regional governance and national affairs. Currently, he serves as Director of the Hong Kong and Macau Affairs Office, a role ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.